CIN-QUIN Drug Patent Profile
When do Cin-quin patents expire, and what generic alternatives are available?
Cin-quin is a drug marketed by Solvay and is included in five NDAs.
The generic ingredient in CIN-QUIN is quinidine sulfate. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the quinidine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Cin-quin
A generic version of CIN-QUIN was approved as quinidine sulfate by EPIC PHARMA LLC on September 26th, 1983.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for CIN-QUIN?
- What are the global sales for CIN-QUIN?
- What is Average Wholesale Price for CIN-QUIN?
Summary for CIN-QUIN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 5 |
| Raw Ingredient (Bulk) Api Vendors: | 16 |
| Patent Applications: | 1,183 |
| DailyMed Link: | CIN-QUIN at DailyMed |
US Patents and Regulatory Information for CIN-QUIN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Solvay | CIN-QUIN | quinidine sulfate | CAPSULE;ORAL | 085296-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Solvay | CIN-QUIN | quinidine sulfate | TABLET;ORAL | 084932-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Solvay | CIN-QUIN | quinidine sulfate | CAPSULE;ORAL | 085297-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Solvay | CIN-QUIN | quinidine sulfate | TABLET;ORAL | 085299-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Solvay | CIN-QUIN | quinidine sulfate | TABLET;ORAL | 085298-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
